المؤلفون: Winter, SF, Löbel, F, Vaios, EJ, Bertalan, MS, Bussière, M, Shih, HA, Muzikansky, A, Martinez-Lage, M, Vajkoczy, P, Dietrich, J

المصدر: 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie; 20180603-20180606; Münster; DOCP057 /20180618/

مصطلحات موضوعية: ddc: 610, 610 Medical sciences, Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e910b908d0ec80312102407e2290c0f

المؤلفون: Bertalan MS; Division of Vascular Surgery, Department of General Surgery, University of Washington, Harborview Medical Center, Seattle, WA., Ghaffarian A; Division of Vascular Surgery, Department of General Surgery, University of Washington, Harborview Medical Center, Seattle, WA., Hemingway J; Division of Vascular Surgery, Department of General Surgery, University of Washington, Harborview Medical Center, Seattle, WA., Quiroga E; Division of Vascular Surgery, Department of General Surgery, University of Washington, Harborview Medical Center, Seattle, WA., Tran N; Division of Vascular Surgery, Department of General Surgery, University of Washington, Harborview Medical Center, Seattle, WA., Starnes B; Division of Vascular Surgery, Department of General Surgery, University of Washington, Harborview Medical Center, Seattle, WA., Singh N; Division of Vascular Surgery, Department of General Surgery, University of Washington, Harborview Medical Center, Seattle, WA.

المصدر: Journal of vascular surgery cases and innovative techniques [J Vasc Surg Cases Innov Tech] 2023 Dec 19; Vol. 10 (2), pp. 101395. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2024).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101701125 Publication Model: eCollection Cited Medium: Print ISSN: 2468-4287 (Print) Linking ISSN: 24684287 NLM ISO Abbreviation: J Vasc Surg Cases Innov Tech Subsets: PubMed not MEDLINE

المؤلفون: Prakadan SM; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Alvarez-Breckenridge CA; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Neurosurgery, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Markson SC; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Kim AE; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Klein RH; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Nayyar N; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Navia AW; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Kuter BM; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Kolb KE; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Bihun I; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Mora JL; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Bertalan MS; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Shaw B; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., White M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Kaplan A; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Stocking JH; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Wadsworth MH 2nd; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Lee EQ; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chukwueke U; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wang N; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Subramanian M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Rotem D; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA., Cahill DP; Department of Neurosurgery, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Adalsteinsson VA; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA., Miller JW; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA., Sullivan RJ; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Carter SL; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. carter.scott@jimmy.harvard.edu.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. carter.scott@jimmy.harvard.edu.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA. carter.scott@jimmy.harvard.edu., Brastianos PK; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. pbrastianos@mgh.harvard.edu.; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA. pbrastianos@mgh.harvard.edu.; Massachusetts General Hospital Cancer Center, Boston, MA, USA. pbrastianos@mgh.harvard.edu., Shalek AK; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA. shalek@mit.edu.; Division of Health Science & Technology, Harvard Medical School, Cambridge, MA, USA. shalek@mit.edu.; Program in Computational & Systems Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.

المصدر: Nature communications [Nat Commun] 2021 Nov 25; Vol. 12 (1), pp. 7007. Date of Electronic Publication: 2021 Nov 25.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Prakadan SM; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Alvarez-Breckenridge CA; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Neurosurgery, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Markson SC; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Kim AE; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Klein RH; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Nayyar N; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Navia AW; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Kuter BM; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Kolb KE; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Bihun I; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Mora JL; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Bertalan MS; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Shaw B; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., White M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Kaplan A; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Stocking JH; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Wadsworth MH 2nd; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA., Lee EQ; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chukwueke U; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wang N; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Subramanian M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Rotem D; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA., Cahill DP; Department of Neurosurgery, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA., Adalsteinsson VA; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA., Miller JW; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA., Sullivan RJ; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Carter SL; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. carter.scott@jimmy.harvard.edu.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. carter.scott@jimmy.harvard.edu.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA. carter.scott@jimmy.harvard.edu., Brastianos PK; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. pbrastianos@mgh.harvard.edu.; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, MA, USA. pbrastianos@mgh.harvard.edu.; Massachusetts General Hospital Cancer Center, Boston, MA, USA. pbrastianos@mgh.harvard.edu., Shalek AK; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Broad Institute, Harvard University & Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, & Massachusetts General Hospital, Cambridge, MA, USA. shalek@mit.edu.; Division of Health Science & Technology, Harvard Medical School, Cambridge, MA, USA. shalek@mit.edu.; Program in Computational & Systems Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. shalek@mit.edu.

المصدر: Nature communications [Nat Commun] 2021 Oct 12; Vol. 12 (1), pp. 5955. Date of Electronic Publication: 2021 Oct 12.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms/*drug therapy , CTLA-4 Antigen/*immunology , Immune Checkpoint Inhibitors/*therapeutic use , Meningeal Carcinomatosis/*drug therapy , Meningeal Neoplasms/*drug therapy , Programmed Cell Death 1 Receptor/*immunology , Tumor Microenvironment/*drug effects, Adult ; Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Brain Neoplasms/immunology ; Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/genetics ; Cell-Free Nucleic Acids/genetics ; Cell-Free Nucleic Acids/immunology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immunotherapy ; Interferon-gamma/genetics ; Interferon-gamma/immunology ; Ipilimumab/therapeutic use ; Male ; Meningeal Carcinomatosis/immunology ; Meningeal Carcinomatosis/mortality ; Meningeal Carcinomatosis/pathology ; Meningeal Neoplasms/immunology ; Meningeal Neoplasms/mortality ; Meningeal Neoplasms/pathology ; Middle Aged ; Nivolumab/therapeutic use ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/genetics ; Single-Cell Analysis ; Survival Analysis ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology

المؤلفون: White MD; Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston.; Cancer Center, Massachusetts General Hospital, Boston.; Division of Comprehensive Neurology, Massachusetts General Hospital, Harvard Medical School, Boston.; Division of Neuro-Oncology, University of Rochester School of Medicine, Rochester, New York., Klein RH; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Shaw B; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts., Kim A; Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston.; Cancer Center, Massachusetts General Hospital, Boston., Subramanian M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts.; Alnylam Pharmaceuticals, Cambridge, Massachusetts., Mora JL; Cancer Center, Massachusetts General Hospital, Boston.; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts., Giobbie-Hurder A; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Nagabhushan D; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts., Jain A; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts., Singh M; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts., Kuter BM; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts.; Boston University, Boston, Massachusetts., Nayyar N; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts., Bertalan MS; Cancer Center, Massachusetts General Hospital, Boston.; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts.; Geisel School of Medicine, Dartmouth College, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Stocking JH; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts.; University of Colorado School of Medicine, Aurora., Markson SC; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lastrapes M; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; University of Texas Health Science Center at Houston, Houston., Alvarez-Breckenridge C; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston.; The University of Texas MD Anderson Cancer Center, Houston., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston., Gydush G; Broad Institute of MIT and Harvard, Boston, Massachusetts., Rhoades J; Broad Institute of MIT and Harvard, Boston, Massachusetts., Rotem D; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Tessera Therapeutics, Cambridge, Massachusetts., Adalsteinsson VA; Broad Institute of MIT and Harvard, Boston, Massachusetts., Mahar M; Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston.; Cancer Center, Massachusetts General Hospital, Boston., Kaplan A; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts.; University of Massachusetts, Boston, Massachusetts., Oh K; Cancer Center, Massachusetts General Hospital, Boston., Sullivan RJ; Cancer Center, Massachusetts General Hospital, Boston.; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts., Gerstner E; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston.; Department of Radiology, Harvard Medical School, Harvard University, Boston, Massachusetts., Carter SL; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Division of Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Brastianos PK; Cancer Center, Massachusetts General Hospital, Boston.; Broad Institute of MIT and Harvard, Boston, Massachusetts.; Department of Medicine, Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts.

المصدر: JAMA network open [JAMA Netw Open] 2021 Aug 02; Vol. 4 (8), pp. e2120040. Date of Electronic Publication: 2021 Aug 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Diagnostic Tests, Routine*, Circulating Tumor DNA/*cerebrospinal fluid , Meningeal Neoplasms/*cerebrospinal fluid , Meningeal Neoplasms/*diagnosis , Meningeal Neoplasms/*genetics , Neoplasms/*complications , Neoplasms/*genetics, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Neoplasms, Second Primary/cerebrospinal fluid ; Neoplasms, Second Primary/diagnosis ; Neoplasms, Second Primary/genetics ; Predictive Value of Tests

المؤلفون: Brastianos PK; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. pbrastianos@mgh.harvard.edu., Lee EQ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Cohen JV; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Tolaney SM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Lin NU; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wang N; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Chukwueke U; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., White MD; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Nayyar N; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Kim A; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Alvarez-Breckenridge C; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Krop I; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Mahar MK; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Bertalan MS; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Shaw B; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Mora JL; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Goss N; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Subramanian M; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Nayak L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Dietrich J; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Forst DA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Nahed BV; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Batchelor TT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Shih HA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Gerstner ER; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lawrence D; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Giobbie-Hurder A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Carter SL; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Oh K; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Cahill DP; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Sullivan RJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

المصدر: Nature medicine [Nat Med] 2020 Aug; Vol. 26 (8), pp. 1280-1284. Date of Electronic Publication: 2020 Jun 02.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Breast Neoplasms/*drug therapy , Lung Neoplasms/*drug therapy , Meningeal Carcinomatosis/*drug therapy , Ovarian Neoplasms/*drug therapy, Antibodies, Monoclonal, Humanized/adverse effects ; Breast Neoplasms/pathology ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Female ; Humans ; Hyperglycemia/chemically induced ; Hyperglycemia/pathology ; Lung Neoplasms/pathology ; Meningeal Carcinomatosis/pathology ; Nausea/chemically induced ; Nausea/pathology ; Neoplasm Metastasis ; Ovarian Neoplasms/pathology ; Vomiting/chemically induced ; Vomiting/pathology

المؤلفون: Brastianos PK; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. pbrastianos@mgh.harvard.edu., Lee EQ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Cohen JV; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Tolaney SM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Lin NU; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wang N; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Chukwueke U; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., White MD; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Nayyar N; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Kim A; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Alvarez-Breckenridge C; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Krop I; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Mahar MK; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Bertalan MS; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Shaw B; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Mora JL; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Goss N; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Subramanian M; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Nayak L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Dietrich J; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Forst DA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Nahed BV; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Batchelor TT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Shih HA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Gerstner ER; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lawrence D; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Giobbie-Hurder A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Carter SL; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Oh K; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Cahill DP; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Sullivan RJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

المصدر: Nature medicine [Nat Med] 2020 Aug; Vol. 26 (8), pp. 1309.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Chi AS; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Cahill DP; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Reardon DA; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA., Wen PY; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA., Mikkelsen T; Ontario Brain Institute, Toronto, Ontario, Canada.; Henry Ford Hospital, Detroit, MI., Peereboom DM; Cleveland Clinic, Cleveland, OH., Wong ET; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA., Gerstner ER; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Dietrich J; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Plotkin SR; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Norden AD; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA., Lee EQ; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA., Nayak L; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA., Tanaka S; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Wakimoto H; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Lelic N; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Koerner MV; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Klofas LK; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Bertalan MS; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Arrillaga-Romany IC; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Betensky RA; Harvard School of Public Health, Boston, MA., Curry WT; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Borger DR; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Balaj L; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Kitchen RR; Exosome Diagnostics, Waltham, MA., Chakrabortty SK; Exosome Diagnostics, Waltham, MA., Valentino MD; Exosome Diagnostics, Waltham, MA., Skog J; Exosome Diagnostics, Waltham, MA., Breakefield XO; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Iafrate AJ; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Batchelor TT; Massachusetts General Hospital and Harvard Medical School, Boston, MA.

المصدر: JCO precision oncology [JCO Precis Oncol] 2020 Jun 08; Vol. 4. Date of Electronic Publication: 2020 Jun 08 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE

المؤلفون: Neftel C; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Institute of Pathology, Faculty of Biology and Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland., Laffy J; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel., Filbin MG; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA., Hara T; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Shore ME; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Rahme GJ; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Richman AR; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Silverbush D; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Shaw ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA., Hebert CM; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Dewitt J; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Gritsch S; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Perez EM; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Gonzalez Castro LN; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA., Lan X; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Druck N; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Rodman C; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Dionne D; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Kaplan A; Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA., Bertalan MS; Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA., Small J; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA., Pelton K; Department of Oncologic Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Becker S; Department of Oncologic Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bonal D; Center for Biomedical Imaging in Oncology, Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nguyen QD; Center for Biomedical Imaging in Oncology, Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Servis RL; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Fung JM; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Mylvaganam R; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Mayr L; Center for Biomedical Imaging in Oncology, Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gojo J; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, 1090, Austria., Haberler C; Institute of Neurology, Medical University of Vienna, Vienna, 1090, Austria., Geyeregger R; Children's Cancer Research Institute (CCRI), St. Anna Kinderspital, Medical University of Vienna, Vienna, 1090, Austria., Czech T; Department of Neurosurgery, Medical University of Vienna, Vienna, 1090, Austria., Slavc I; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, 1090, Austria., Nahed BV; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA., Curry WT; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA., Carter BS; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA., Wakimoto H; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA., Brastianos PK; Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA., Batchelor TT; Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA., Stemmer-Rachamimov A; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Martinez-Lage M; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Frosch MP; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Stamenkovic I; Institute of Pathology, Faculty of Biology and Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland., Riggi N; Institute of Pathology, Faculty of Biology and Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland., Rheinbay E; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Monje M; Departments of Neurology, Neurosurgery, Pediatrics and Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Rozenblatt-Rosen O; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114 USA., Patel AP; Department of Neurological Surgery, University of Washington, Seattle, USA., Hunter T; Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Verma IM; Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Ligon KL; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Oncologic Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Louis DN; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., Regev A; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Department of Biology, MIT, Cambridge, MA 02139, USA., Bernstein BE; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Tirosh I; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel. Electronic address: Itayt@weizmann.ac.il., Suvà ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address: Suva.Mario@mgh.harvard.edu.

المصدر: Cell [Cell] 2019 Aug 08; Vol. 178 (4), pp. 835-849.e21. Date of Electronic Publication: 2019 Jul 18.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms/*genetics , Cell Plasticity/*genetics , Glioblastoma/*genetics, Adolescent ; Aged ; Animals ; Brain Neoplasms/pathology ; Cell Line, Tumor ; Cell Lineage/genetics ; Child ; Cohort Studies ; Disease Models, Animal ; Female ; Genetic Heterogeneity ; Glioblastoma/pathology ; Heterografts ; Humans ; Infant ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Inbred NOD ; Middle Aged ; Mutation ; RNA-Seq ; Single-Cell Analysis/methods ; Tumor Microenvironment/genetics

المؤلفون: Fujio S; Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.; Pituitary Disorders Center, Kagoshima University Hospital, Kagoshima, Japan., Juratli TA; Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Arita K; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Hirano H; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Nagano Y; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.; Pituitary Disorders Center, Kagoshima University Hospital, Kagoshima, Japan., Takajo T; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Yoshimoto K; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.; Pituitary Disorders Center, Kagoshima University Hospital, Kagoshima, Japan., Bihun IV; Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Kaplan AB; Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Nayyar N; Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Fink AL; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Bertalan MS; Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Tummala SS; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Curry WT Jr; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Jones PS; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Martinez-Lage M; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Barker FG; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Brastianos PK; Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

المصدر: Neurosurgery [Neurosurgery] 2019 Aug 01; Vol. 85 (2), pp. 204-210.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 7802914 Publication Model: Print Cited Medium: Internet ISSN: 1524-4040 (Electronic) Linking ISSN: 0148396X NLM ISO Abbreviation: Neurosurgery Subsets: MEDLINE

مواضيع طبية MeSH: Craniopharyngioma/*genetics , Craniopharyngioma/*pathology , Pituitary Neoplasms/*genetics , Pituitary Neoplasms/*pathology , Proto-Oncogene Proteins B-raf/*genetics, Adolescent ; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Molecular Targeted Therapy/methods ; Mutation ; Neoadjuvant Therapy/methods ; Patient Selection ; Sensitivity and Specificity